3-Amino-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid, 98%, 250mg

4-Hydrazinyl-3-(trifluoromethyl)benzonitrile, 97%, 1g

METHYL 4-AMINO-3,6-DICHLOROPICOLINATE, 95.0%, 5g

5-methyl-2,5,7-triazaspiro[3.4]octan-6-one hydrochloride, 95.0%, 1g

(2,6-Dichlorophenyl)acetic acid ethyl ester, 99.0%, 5g

Methyl 2-formyl-4-methyl-4H-furo[3,2-b]pyrrole-5-carboxylate, 1g

2-(methylthio)-1,3-thiazole-4-carboxylic acid, 95.0%, 1g

Etoxazole>98.0%(HPLC)1g

Ethyl 4-chloropyrimidine-5-carboxylate, 95.0%, 5g

tert-Butyl 4-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)piperazine-1-carboxylate, 95.0%, 5g

GC-Kapillarsäule ROTI®Cap-1, unpolar, L 12 m, Ø-Innen 0,20 mm, Filmd. 0,20 µm, 1 Stück

(1S,5S)-3-benzyl-3,6-diazabicyclo[3.2.2]nonane dihydrochloride hydrate, 95.0%, 1g

(5-(4-Chlorophenyl)-3-isoxazolyl)methanol, 95.0%, 500mg